CN Patent

CN103402996A — 可用于治疗年龄相关性黄斑变性(amd)的吲哚化合物或其类似物

Assigned to Novartis AG · Expires 2013-11-20 · 12y expired

What this patent protects

本发明提供了式(I)化合物、本发明的化合物的制备方法及其治疗应用。本发明还提供了药理学活性剂的组合产品和药物组合物。

USPTO Abstract

本发明提供了式(I)化合物、本发明的化合物的制备方法及其治疗应用。本发明还提供了药理学活性剂的组合产品和药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN103402996A
Jurisdiction
CN
Classification
—
Expires
2013-11-20
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.